Sandrine Flory
Director/Board Member bei TRANSGENE
Profil
Sandrine Flory is currently a Director at Transgene SA, TSGH SAS, GeNeuro SA (Switzerland), and Institut Mérieux SA. She previously worked as the Chief Financial Officer-EMEA Division at bioMérieux SA. Ms. Flory holds a graduate degree from Universite Lumiere Lyon 2.
Aktive Positionen von Sandrine Flory
| Unternehmen | Position | Beginn |
|---|---|---|
| TRANSGENE | Director/Board Member | 01.01.2021 |
| GENEURO SA | Director/Board Member | 18.03.2024 |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Director of Finance/CFO | 01.01.2020 |
TSGH SAS
 TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Director/Board Member | 01.01.2002 |
Ehemalige bekannte Positionen von Sandrine Flory
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMÉRIEUX | Corporate Officer/Principal | 01.01.2020 |
Ausbildung von Sandrine Flory
| Universite Lumiere Lyon 2 | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| TRANSGENE | Health Technology |
| BIOMÉRIEUX | Health Technology |
| GENEURO SA | Health Technology |
| Private Unternehmen | 2 |
|---|---|
TSGH SAS
TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Finance |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Health Technology |
